The CDC admitted this week to finding more cases of rare heart inflammation in young adults than was expected after receiving COVID vaccine shots.
The CDC presentation shows a surge in myocarditis/pericarditis cases in young adults after their second dose of the COVID vaccine.
A CDC safety group said there’s a “likely association” between a rare heart inflammatory condition in adolescents and young adults mostly after they’ve received their second Covid-19 vaccine shot, citing the most recent data available.
There have been more than 1,200 cases of a rare heart inflammation condition in people who received Pfizer’s or Moderna’s Covid-19 vaccine, according to a slide presentation published Wednesday ahead of an advisory meeting at the Centers for Disease Control and Prevention.
The CDC’s Advisory Committee on Immunization Practices is holding a meeting to discuss rare, but higher-than-expected, reports of myocarditis or pericarditis in 16- to-24-year-olds after receiving the mRNA vaccines. Myocarditis is the inflammation of the heart muscle, while pericarditis is the inflammation of the membrane surrounding the heart.
1/ THIS IS NOT OKAY.@cdcgov just posted its myocarditis/pericarditis update. They are now admitting that post-second dose risk in people under 25 could be over 200x the background rate (and that’s not accounting for underreporting).
But the real news is even worse… pic.twitter.com/dP1IH5ZLqs
— Alex Berenson (@AlexBerenson) June 23, 2021